Causal Genetic Inference Using Haplotypes as Instrumental Variables

Genetic Epidemiology

Volumn 40, Issue 1, 2016, Pages 35-44

  Wang, Fan ^a   Meyer, Nuala J ^a   Walley, Keith R ^b   Russell, James A ^b   Feng, Rui ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Causal effect estimate; Haplotype; Instrumental variable (IV); Mendelian randomization

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1BETA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENETIC INFERENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; POPULATION GENETIC PARAMETERS; PREDICTION; PROTEIN EXPRESSION; SEPTIC SHOCK; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENETICS; MENDELIAN RANDOMIZATION ANALYSIS; PROCEDURES;

COMPUTER SIMULATION; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; MENDELIAN RANDOMIZATION ANALYSIS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SHOCK, SEPTIC;

EID: 84951739336     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21940     Document Type: Article

References (39)

1. Albert FW, Kruglyak L. 2015. The role of regulatory variation in complex traits and disease. Nat Rev Genet 16(4):197-212.
2. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, Network ftC-R. 2003. Current epidemiology of septic shock: the CUB-Réa network. Am J Respir Crit Care Med 168(2):165-172.
3. Barrett JC. 2009. Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 4(10):1-5.
4. Brunner EJ, Kivimaki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP and others. 2008. Inflammation, insulin resistance, and diabetes-Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5(8):e155.
5. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS and others. 2005. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102(9):3389-3394.
6. Chan SK, Griffith OL, Tai IT, Jones SJ. 2008. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 17(3):543-552.
7. Davey Smith G, Harbord R, Ebrahim S. 2004. Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal? QJM 97(3):163-166.
8. Dempster AP, Laird NM, Rubin DB. 1977. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Series B 39(1):1-38.
9. Dermitzakis ET. 2008. From gene expression to disease risk. Nat Genet 40(5):492-493.
10. Didelez V, Sheehan N. 2007. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16(4):309-330.
11. Didelez V, Meng S, Sheehan NA. 2010. Assumptions of IV methods for observational epidemiology. Stat Sci 25(1):22-40.
12. Ein-Dor L, Zuk O, Domany E. 2006. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 103(15):5923-5928.
13. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, Carlson S, Helgason A, Walters GB, Gunnarsdottir S and others. 2008. Genetics of gene expression and its effect on disease. Nature 452(7186):423-428.
14. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M and others. 2002. The structure of haplotype blocks in the human genome. Science 296(5576):2225-2229.
15. Glover F. 1989. Tabu search-part I. ORSA J Comput 1(3):190-206.
16. Hanash S. 2003. Disease proteomics. Nature 422(6928):226-232.
17. Hausman JA. 1978. Specification tests in econometrics. Econometrica 46(6):1251-1271.
18. Hocking RR. 1976. A Biometrics invited paper. The analysis and selection of variables in linear regression. Biometrics 32(1):1-49.
19. Hu W-C. 2013. Sepsis is a syndrome with hyperactivity of TH17-like innate immunity and hypoactivity of adaptive immunity. Manuscript. arXiv:1311.4747.
20. Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E, Mohan A, Khan RA, Whittle J and others. 2011. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 140(5):1223-1231.
21. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. 2008a. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133-1163.
22. Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Smith GD. 2008b. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133-1163.
23. Leek JT, Storey JD. 2007. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3(9):1724-1735.
24. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, Wade MS, Li Y, Liang L, Zareparsi S, Swaroop A. 2006. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38(9):1049-1054.
25. Li Y, Sung WK, Liu JJ. 2007. Association mapping via regularized regression analysis of single-nucleotide-polymorphism haplotypes in variable-sized sliding windows. Am J Hum Genet 80(4):705-715.
26. Lin W, Feng R, Li H. 2014. Regularization methods for high-dimensional instrumental variables regression with an application to genetical genomics. J Am Stat Assoc 110(509):270-288.
27. Meyer NJ, Ferguson JF, Feng R, Wang F, Patel PN, Li M, Xue C, Qu L, Liu Y, Boyd JH and others. 2014. A functional synonymous coding variant in the IL1RN gene associates with survival in septic shock. Am J Respir Crit Care Med 190(6):656-664.
28. Murray MP. 2006. Avoiding invalid instruments and coping with weak instruments. J Econ Perspect 20(4):111-132.
29. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA. 2012. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 21(3):223-242.
30. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904-909.
31. Schaid DJ. 2004. Evaluating associations of haplotypes with traits. Genet Epidemiol 27(4):348-364.
32. Schanstra JP, Mischak H. 2014. Proteomic urinary biomarker approach in renal disease: from discovery to implementation. Pediatr Nephrol 30(5):713-725.
33. Smith GD, Ebrahim S. 2004. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33(1):30-42.
34. Terza JV, Basu A, Rathouz PJ. 2008. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ 27(3):531-543.
35. Tibshirani R, Wang P. 2008. Spatial smoothing and hot spot detection for CGH data using the fused lasso. Biostatistics 9(1):18-29.
36. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, Hattersley AT, Ebrahim S, Lowe GD, Rumley A and others. 2005. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 366(9501):1954-1959.
37. Wang P, Dawson JA, Keller MP, Yandell BS, Thornberry NA, Zhang BB, Wang IM, Schadt EE, Attie AD, Kendziorski C. 2011. A model selection approach for expression quantitative trait loci (eQTL) mapping. Genetics 187(2):611-621.
38. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. 2002. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53(2):79-91.
39. Zhang M, Yao C, Guo Z, Zou J, Zhang L, Xiao H, Wang D, Yang D, Gong X, Zhu J and others. 2008. Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics 24(18):2057-2063.